|
REVB Revelation Biosciences Inc 1810560 |
| Balance Sheet |
|
Current Assets
|
6,565,717 |
|
Assets
|
6,622,049 |
|
Current Liabilities
|
1,913,667 |
|
Liabilities
|
1,913,667 |
|
Equity
|
4,708,382 |
|
Shares Out
|
1,643,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-18,321,276 |
|
Investing Cash Flow
|
-19,171 |
| Market Analysis |
Market Cap
|
1,476,424 |
|
Price
|
2.94 |
|
BVPS
|
2.87 |
|
PB
|
1.08 |
|
EPS
|
-29.75 |
|
PS
|
0.08 |
|
FCF
|
-18,340,447 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view REVB documents filed with the SEC.
REVB Filings
Clear
